These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 36652905)

  • 1. Current understanding of the intratumoral microbiome in various tumors.
    Xue C; Chu Q; Zheng Q; Yuan X; Su Y; Bao Z; Lu J; Li L
    Cell Rep Med; 2023 Jan; 4(1):100884. PubMed ID: 36652905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.
    Gao F; Yu B; Rao B; Sun Y; Yu J; Wang D; Cui G; Ren Z
    Front Immunol; 2022; 13():1051987. PubMed ID: 36466871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
    Wang M; Yu F; Li P
    Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the intratumoral microbiome in tumor progression and therapeutics implications.
    Meng YF; Fan ZY; Zhou B; Zhan HX
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189014. PubMed ID: 37918451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral microbiome and gastrointestinal cancers.
    Li S; Li Q; Lu W
    Front Oncol; 2022; 12():1047015. PubMed ID: 36523986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational methods and challenges in analyzing intratumoral microbiome data.
    Wang Q; Liu Z; Ma A; Li Z; Liu B; Ma Q
    Trends Microbiol; 2023 Jul; 31(7):707-722. PubMed ID: 36841736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral microorganisms in tumors of the digestive system.
    Xuan M; Gu X; Liu Y; Yang L; Li Y; Huang D; Li J; Xue C
    Cell Commun Signal; 2024 Jan; 22(1):69. PubMed ID: 38273292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
    Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
    JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Tumor Microbiome and Oral Bacteria and Intestinal Dysbiosis in Canine Mammary Tumor.
    Zheng HH; Du CT; Yu C; Tang XY; Huang RL; Zhang YZ; Gao W; Xie GH
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.
    Yang L; Li A; Wang Y; Zhang Y
    Signal Transduct Target Ther; 2023 Jan; 8(1):35. PubMed ID: 36646684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes.
    Chang CM; Pekkle Lam HY
    Anticancer Res; 2024 Jun; 44(6):2271-2285. PubMed ID: 38821615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the role of intratumoral bacteria in digestive system cancers: current insights and future perspectives.
    Lu W; Aihaiti A; Abudukeranmu P; Liu Y; Gao H
    J Transl Med; 2024 Jun; 22(1):545. PubMed ID: 38849871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral bacteria are an important "accomplice" in tumor development and metastasis.
    Wang G; He X; Wang Q
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188846. PubMed ID: 36496095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral microbiota: new frontiers in tumor immunity.
    Zhang Z; Liao Y; Tang D
    Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness of intratumoral bacteria and their potential application in cancer treatment.
    Liang Y; Li Q; Liu Y; Guo Y; Li Q
    Discov Oncol; 2023 May; 14(1):57. PubMed ID: 37148441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
    Doocey CM; Finn K; Murphy C; Guinane CM
    BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral Microbiome of Human Primary Liver Cancer.
    Qu D; Wang Y; Xia Q; Chang J; Jiang X; Zhang H
    Hepatol Commun; 2022 Jul; 6(7):1741-1752. PubMed ID: 35191218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human microbiome and cancer: a diagnostic and therapeutic perspective.
    Kandalai S; Li H; Zhang N; Peng H; Zheng Q
    Cancer Biol Ther; 2023 Dec; 24(1):2240084. PubMed ID: 37498047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.